Powder Pharmaceuticals (HK) Co., Ltd ("HK Powder") is located at Hong Kong Science Park, it operates a cleanroom with an area of approximately 1,700 square feet which meets the ISO-8 class 100,000 requirements. In view of the spread of the COVID-19 worldwide and the demand for masks has surged significantly, since early March this year, HK Powder decided to utilise its cleanroom for mask production in order to help address the imminent shortage of face masks in Hong Kong.
Powder Pharmaceuticals (HK) Co., Ltd is an associated company of Lee's Pharmaceutical Holdings Ltd ("Lee's Pharm"), Hong Kong Stock Code: 950. Lee's Pharm is a research-driven and market-oriented biopharmaceutical company with more than 25 years of operation in the pharmaceutical industry in the PRC. Lee's Pharm is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales and marketing based in Mainland China with global perspectives. The Group has established extensive partnerships with over 20 international companies and currently markets 22 proprietary and licensed-in pharmaceutical products in Mainland China, Hong Kong, Macau and Taiwan. The Company focuses on several key disease areas such as cardiovascular, woman health, paediatrics, rare diseases, oncology, ophthalmology, dermatology, obstetrics and urology. It has more than 60 products under different development stages stemming from both internal research and development as well as from the licensing of development, commercialisation, and manufacturing rights from various United States, European and Japanese companies.